Influence of competitive level and tactical position on parameters of aerobic performance in professional soccer athletes from Brazil

Este estudo objetivou verificar a influência do nível competitivo e da posição tática sobre parâmetros relacionados ao desempenho aeróbio de atletas profissionais de futebol. Foram analisadas 453 avaliações ergoespirométricas de atletas profissionais de futebol (42 goleiros, 92 zagueiros, 61 laterais, 174 meio-campistas e 84 atacantes) que atuavam em quatro níveis competitivos: Campeonato Nacional Série A; Série B; Série C; e Campeonato Estadual. Não foram encontradas diferenças nos valores médios de consumo máximo de oxigênio (VO2max) e segundo limiar ventilatório (LV2) entre os níveis competitivos (p > 0,05). Os goleiros apresentaram VO2max e LV2 (56 e 50 mL/kg/min, respectivamente) significativamente inferiores aos zagueiros (59 e 52 mL/kg.min; p = 0,002 e p = 0,028), laterais (60 e 53 mL/kg.min; p ; 0.05). The goalkeepers showed VO2max and LV2 (56 and 50 mL/kg.min, respectively) significant lower than full backs (59 and 52 mL/kg.min; p = 0.002 e p = 0.028), sideways (60 and 53 mL/kg.min; p = 0.000 e p = 0.004), midfields (59 and 52 mL/kg.min; p = 0.002 e p = 0.031) and forwards (59 and 52 mL/kg.min; p = 0.047 e p = 0.036). Therefore, the findings suggest that: 1) the aerobic performance does not differ according the competitive level; and 2) the goalkeepers have aerobic performance inferior to out-field players, which do not show differences between them

Analysis of effects of kinesiotherapy and hydrokinesiotherapy on the quality of life of patients with fibromyalgia: a randomized clinical trial

OBJETIVO: Verificar e comparar os efeitos da hidrocinesioterapia e da cinesioterapia na qualidade de vida de pacientes portadoras de fibromialgia. MATERIAIS E MÉTODOS: Foi realizado um ensaio clínico randomizado, cego, para os avaliadores. Para avaliar a qualidade de vida, utilizou-se o questionário genérico SF-36 a fim de analisar os aspectos físicos e psicológicos em 24 pacientes do sexo feminino, portadoras de fibromialgia, com idade de 30 a 55 anos, alocadas aleatoriamente em dois grupos: hidrocinesioterapia e cinesioterapia. Durante um período de 23 semanas, as pacientes foram submetidas a alongamentos e exercícios aeróbios de baixa intensidade com duração de uma hora cada sessão (em ambos os grupos). RESULTADOS: Observou-se melhora estatisticamente significante (p < 0,05) na maior parte dos aspectos abordados pelo SF-36 em ambos os grupos. CONCLUSÃO: A hidrocinesioterapia promoveu um relaxamento muscular favorável para a melhora da qualidade de vida, porém, não foi o fator principal para amenizar os efeitos da patologia, uma vez que a cinesioterapia também proporcionou efeitos benéficos para a promoção do bem-estar dessas pacientes. Portanto, os alongamentos e os exercícios aeróbios de baixa intensidade empregados em ambos os protocolos são os prováveis responsáveis pelos efeitos benéficos observados nas duas modalidades terapêuticas analisadas.OBJECTIVE: To verify and compare the effects of hydrokinesiotherapy and kinesiotherapy in the quality of life of patients with fibromyalgia. MATERIALS AND METHODS: It was realized a randomized clinical trial, blinded, to observers. To evaluate the quality of life, it was used the generic questionnaire SF- 36 in order to analyze the physical and psychological aspects, in 24 female patients with fibromyalgia, between 30 and 55 years old, placed aleatorialy in two groups: hydrokinesiotherapy and kinesiotherapy. During a period of 23 weeks, the patients were submitted to stretching and aerobic exercises of low intensity with one hour of duration each section (in both groups). RESULTS: It was observed statistically significant increase (p < 0,05) in the majority of the aspects of SF-36 in both groups. CONCLUSION: The hydrokinesiotherapy provides a favorable muscle relaxing to improve the quality of life, however it is not the main factor to decrease the effects of the pathology, since the kinesiotherapy also provided beneficent effects to promote the well being of these patients. Therefore, stretching and aerobic exercises of low intensity employed in both protocols are the probable responsibles by positive effects observed in both therapeutic modalities analysed

A laserterapia de baixa potência melhora o desempenho muscular mensurado por dinamometria isocinética em humanos

A fadiga muscular é uma nova área de pesquisa em laserterapia, com poucos estudos conduzidos. Embora a laserterapia de baixa potência (LBP) previamente ao exercício tenha apresentado resultados positivos no retardo da fadiga musculoesquelética, ainda não foi estudada utilizando-se a dinamometria isocinética para mensurar desempenho e fadiga muscular. Este estudo tem o objetivo de avaliar os efeitos da LBP (655 nm, 50 mW, 2,4 J por ponto e 12 J de energia total) sobre o desempenho e fadiga muscular do músculo tibial anterior, utilizando dinamometria isocinética (30 repetições de contração concêntrica) em 14 indivíduos saudáveis sedentários do sexo masculino. Os voluntários foram avaliados ao efetuar 30 repetições isocinéticas de dorsiflexão de tornozelo à velocidade angular de 240°.seg-1. Os resultados mostram que, quando os voluntários foram tratados com LBP antes do exercício, os valores do pico de torque (30,91±5,86 N.m) foram significativamente superiores, comparados a três medições anteriores sem a aplicação de LBP (24,92±7,45 N.m, pSkeletal muscle fatigue is a novel research area in laser therapy, there being few studies carried out. Though low-level laser therapy (LLLT) applied prior to exercise has showed positive results in delaying skeletal muscle fatigue, no studies could be found that measured muscle performance and fatigue by means of isokinetic dynamometry. This clinical trial aims at assessing the effects of LLLT (655 nm, 50 mW and 12 J total energy delivered) on anterior tibialis muscle performance and fatigue by means of isokinetic dynamometry (30 concentric-mode repetitions at 240º.sec-1 angular speed) in 14 healthy male subjects. Results show that, when volunteers had been treated with LLLT prior to exercise, torque peak values (30.91±5.86 N.m) were significantly higher than those of three previous measurements with no LLLT (24.92±7.45 N.m,

Effects and parameters of the photobiomodulation in experimental models of third-degree burn: systematic reviewanalysis / Efeitos e parâmetros da fotobiomodulação em modelos experimentais de queimadura de terceiro grau: revisão sistemática

This systematic review was performed to identify the role of photobiomodulation therapy in experimental models of third-degree burns used to induce oxidative stress. EMBASE, PubMed, and CINAHL databases were searched for studies published between January 2003 and January 2018 on the topics of photobiomodulation therapy and third-degree burns. Any study that assessed the effects of photobiomodulation therapy in animal models of third-degree burns was included in the analysis. A total of 17 studies were selected from 1182 original articles targeted on photobiomodulation therapy and third-degree burns. Two independent raters with a structured tool for rating the research quality critically assessed the articles. Although the small number of studies limits the conclusions, the current literature research indicates that photobiomodulation therapy can be an effective short-term approach to accelerate the healing process of third-degree burns, to increase and modulate the inflammatory process, to accelerate the proliferation of fibroblasts, and to enhance the quality of the collagen network. However, differences still exist in the terminology used to describe the parameters and the dose of photobiomodulation therapy

Superpulsed low-level laser therapy protects skeletal muscle of mdx mice against damage, inflammation and morphological changes delaying dystrophy progression.

Aim: To evaluate the effects of preventive treatment with low-level laser therapy (LLLT) on progression of dystrophy in mdx mice. Methods: Ten animals were randomly divided into 2 experimental groups treated with superpulsed LLLT (904 nm, 15 mW, 700 Hz, 1 J) or placebo-LLLT at one point overlying the tibialis anterior muscle (bilaterally) 5 times per week for 14 weeks (from 6th to 20th week of age). Morphological changes, creatine kinase (CK) activity and mRNA gene expression were assessed in animals at 20th week of age. Results: Animals treated with LLLT showed very few morphological changes in skeletal muscle, with less atrophy and fibrosis than animals treated with placebo-LLLT. CK was significantly lower (p = 0.0203) in animals treated with LLLT (864.70 U.l−1, SEM 226.10) than placebo (1708.00 U.l−1, SEM 184.60). mRNA gene expression of inflammatory markers was significantly decreased by treatment with LLLT (p<0.05): TNF-α (placebo-control = 0.51 µg/µl [SEM 0.12], - LLLT = 0.048 µg/µl [SEM 0.01]), IL-1β (placebo-control = 2.292 µg/µl [SEM 0.74], - LLLT = 0.12 µg/µl [SEM 0.03]), IL-6 (placebo-control = 3.946 µg/µl [SEM 0.98], - LLLT = 0.854 µg/µl [SEM 0.33]), IL-10 (placebo-control = 1.116 µg/µl [SEM 0.22], - LLLT = 0.352 µg/µl [SEM 0.15]), and COX-2 (placebo-control = 4.984 µg/µl [SEM 1.18], LLLT = 1.470 µg/µl [SEM 0.73]). Conclusion: Irradiation of superpulsed LLLT on successive days five times per week for 14 weeks decreased morphological changes, skeletal muscle damage and inflammation in mdx mice. This indicates that LLLT has potential to decrease progression of Duchenne muscular dystrophy

Effect of low-level laser therapy on pain, quality of life and sleep in patients with fibromyalgia: study protocol for a double-blinded randomized controlled trial

BACKGROUND: Low-level laser therapy (LLLT) has been widely used as adjuvant strategy for treatment of musculoskeletal disorders. The light-tissue interaction (photobiostimulation) promotes analgesic and anti-inflammatory effects and improves tissue healing, which could justify the recommendation of this therapy for patients with fibromyalgia, leading to an improvement in pain and possibly minimizing social impact related to this disease. The present study proposes to evaluate the effect of LLLT on tender points in patients with fibromyalgia, correlating this outcome with quality of life and sleep. METHODS/DESIGN: One hundred and twenty patients with fibromyalgia will be treated at the Integrated Health Center and the Sleep Laboratory of the Post Graduate Program in Rehabilitation Sciences of the Nove de Julho University located in the city of Sao Paulo, Brazil. After fulfilling the eligibility criteria, a clinical evaluation and assessments of pain and sleep quality will be carried out and self-administered quality of life questionnaires will be applied. The 120 volunteers will be randomly allocated to an intervention group (LLLT, n = 60) or control group (CLLLT, n = 60). Patients from both groups will be treated three times per week for four weeks, totaling twelve sessions. However, only the LLLT group will receive an energy dose of 6 J per tender point. A standardized 50-minute exercise program will be performed after the laser application. The patients will be evaluated regarding the primary outcome (pain) using the following instruments: visual analog scale, McGill Pain Questionnaire and pressure algometry. The secondary outcome (quality of life and sleep) will be assessed with the following instruments: Medical Outcomes Study 36-item Short-Form Health Survey, Fibromyalgia Impact Questionnaire, Berlin Questionnaire, Epworth Sleepiness Scale and polysomnography. ANOVA test with repeated measurements for the time factor will be performed to test between-groups differences (followed by the Tukey-Kramer post hoc test), and a paired t test will be performed to test within-group differences. The level of significance for the statistical analysis will be set at 5% (P ≤0.05). TRIAL REGISTRATION: The protocol for this study is registered with the Brazilian Registry of Clinical Trials – ReBEC (RBR-42gkzt

Effect of 830 nm low-level laser therapy in exercise-induced skeletal muscle fatigue in humans

Abstract This study aimed to investigate the effect of 830 nm low-level laser therapy (LLLT) on skeletal muscle fatigue. Ten healthy male professional volleyball players entered a crossover randomized double-blinded placebocontrolled trial. Active LLLT (830 nm wavelength, 100 mW output, spot size 0.0028 cm 2 , 200 s total irradiation time) or an identical placebo LLLT was delivered to four points on the biceps humeri muscle immediately before exercises. All subjects performed voluntary biceps humeri contractions with a load of 75% of the maximum voluntary contraction (MVC) force until exhaustion. After active LLLT the mean number of repetitions was significantly higher than after placebo irradiation [mean difference 4.5, standard deviation (SD) ±6.0, P=0.042], the blood lactate levels increased after exercises, but there was no significant difference between the treatments. We concluded that 830 nm LLLT can delay the onset of skeletal muscle fatigue in highintensity exercises, in spite of increased blood lactate levels

Immediate effects of photobiomodulation therapy combined with a static magnetic field on the subsequent performance: a preliminary randomized crossover triple-blinded placebo-controlled trial

There is evidence about the effects of photobiomodulation therapy (PBMT) alone and combined with a static magnetic field (PBMT-sMF) on skeletal muscle fatigue, physical performance and post-exercise recovery in different types of exercise protocols and sports activity. However, the effects of PBMT-sMF to improve the subsequent performance after a first set of exercises are unknown. Therefore, the aim of this study was to investigate the effects of PBMT-sMF, applied between two sets of exercises, on the subsequent physical performance. A randomized, crossover, triple-blinded (assessors, therapist, and volunteers), placebo-controlled trial was carried out. Healthy non-athlete male volunteers were randomized and treated with a single application of PBMT-sMF and placebo between two sets of an exercise protocol performed on isokinetic dynamometer. The order of interventions was randomized. The primary outcome was fatigue index and the secondary outcomes were total work, peak work, and blood lactate levels. Twelve volunteers were randomized and analyzed to each sequence. PBMT-sMF decreased the fatigue index compared to the placebo PBMT-sMF at second set of the exercise protocol (MD = -6.08, 95% CI -10.49 to -1.68). In addition, PBMT-sMF decreased the blood lactate levels post-intervention, and after the second set of the exercise protocol compared to placebo (p<0.05). There was no difference between PBMT-sMF and placebo in the remaining outcomes tested. Volunteers did not report adverse events. Our results suggest that PBMT-sMF is able to decrease skeletal muscle fatigue, accelerating post-exercise recovery and, consequently, increasing subsequent physical performance when applied between two sets of exercises.publishedVersio

Red (660 nm) and infrared (830 nm) low-level laser therapy in skeletal muscle fatigue in humans: what is better?

In animal and clinical trials low-level laser therapy (LLLT) using red, infrared and mixed wavelengths has been shown to delay the development of skeletal muscle fatigue. However, the parameters employed in these studies do not allow a conclusion as to which wavelength range is better in delaying the development of skeletal muscle fatigue. With this perspective in mind, we compared the effects of red and infrared LLLT on skeletal muscle fatigue. A randomized double-blind placebo-controlled crossover trial was performed in ten healthy male volunteers. They were treated with active red LLLT, active infrared LLLT (660 or 830 nm, 50 mW, 17.85 W/cm2, 100 s irradiation per point, 5 J, 1,785 J/cm2 at each point irradiated, total 20 J irradiated per muscle) or an identical placebo LLLT at four points of the biceps brachii muscle for 3 min before exercise (voluntary isometric elbow flexion for 60 s). The mean peak force was significantly greater (p < 0.05) following red (12.14%) and infrared LLLT (14.49%) than following placebo LLLT, and the mean average force was also significantly greater (p < 0.05) following red (13.09%) and infrared LLLT (13.24%) than following placebo LLLT. There were no significant differences in mean average force or mean peak force between red and infrared LLLT. We conclude that both red than infrared LLLT are effective in delaying the development skeletal muscle fatigue and in enhancement of skeletal muscle performance. Further studies are needed to identify the specific mechanisms through which each wavelength acts

Effectiveness of phototherapy incorporated into an exercise program for osteoarthritis of the knee: study protocol for a randomized controlled trial

BACKGROUND: Osteoarthritis is a chronic disease with a multifactor etiology involving changes in bone alignment, cartilage, and other structures necessary to joint stability. There is a need to investigate therapeutic resources that combine different wavelengths as well as different light sources (low-level laser therapy and light-emitting diode therapy) in the same apparatus for the treatment of osteoarthritis. The aim of the proposed study is to analyze the effect of the incorporation of phototherapy into a therapeutic exercise program for individuals with osteoarthritis of the knee. METHODS/DESIGN: A double-blind, controlled, randomized clinical trial will be conducted involving patients with osteoarthritis of the knee. Evaluations will be performed using functional questionnaires before and after the treatment protocols, in a reserved room with only the evaluator and participant present, and no time constraints placed on the answers or evaluations. The following functional tests will also be performed: stabilometry (balance assessment), dynamometry (muscle strength of gluteus medius and quadriceps), algometry (pain threshold), fleximeter (range of motion), timed up-and-go test (functional mobility), and the functional reach test. The participants will then be allocated to three groups through a randomization process using opaque envelopes: exercise program, exercise program + phototherapy, or exercise program + placebo phototherapy, all of which will last for eight weeks. DISCUSSION: The purpose of this randomized clinical trial is to analyze the effect of the incorporation of phototherapy into a therapeutic exercise program for osteoarthritis of the knee. The study will support the practice based on evidence to the use of phototherapy in individuals with a diagnosis of osteoarthritis of the knee. Data will be published after the study is completed. TRIAL REGISTRATION: The protocol for this study has been submitted to Clinical Trials, registration number NCT02102347, on 29 March 2014